| 1 |
Merchant N, Alam A, Bhaskar L. The correlation between hepatocellular carcinoma susceptibility and XRCC1 polymorphisms Arg194Trp, Arg280His, and Arg399Gln – A meta-analysis. Human Gene 2023. [DOI: 10.1016/j.humgen.2023.201165] [Reference Citation Analysis]
|
| 2 |
Elkhoudary AF, Elmougy R, Elsaid A, Wahba Y, Abdel-Aziz AF. Genetic and biochemical studies of hepatic carcinoma in the Egyptian population. J Res Med Sci 2021;26:62. [PMID: 34729070 DOI: 10.4103/jrms.JRMS_846_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 3 |
Rybicka M, Woziwodzka A, Sznarkowska A, Romanowski T, Stalke P, Dręczewski M, Verrier ER, Baumert TF, Bielawski KP. Liver Cirrhosis in Chronic Hepatitis B Patients Is Associated with Genetic Variations in DNA Repair Pathway Genes. Cancers (Basel) 2020;12:E3295. [PMID: 33171788 DOI: 10.3390/cancers12113295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 4 |
Xiong Y, Zhang Q, Ye J, Pan S, Ge L. Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies. PLoS One 2018;13:e0206853. [PMID: 30408066 DOI: 10.1371/journal.pone.0206853] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 5 |
Mattar MM, Zekri AN, Hussein N, Morsy H, Esmat G, Amin MA. Polymorphisms of base-excision repair genes and the hepatocarcinogenesis. Gene 2018;675:62-8. [PMID: 29935355 DOI: 10.1016/j.gene.2018.06.056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Bazgir A, Agha Gholizadeh M, Khosravi A, Mansour Samaei N. The X-ray Repair Cross-Complementing Group 1 Arg399Gln Genetic Polymorphism and Risk of Hepatocellular Carcinoma in an Iranian Population. Middle East J Dig Dis 2018;10:40-4. [PMID: 29682247 DOI: 10.15171/mejdd.2017.89] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 7 |
Chen J, Wang H, Li Z. Association between Polymorphisms of X-Ray Repair Cross Complementing Group 1 Gene and Pancreatic Cancer Risk: a Systematic Review with Meta-Analysis. Pathol Oncol Res 2019;25:897-904. [PMID: 29285737 DOI: 10.1007/s12253-017-0364-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 8 |
Santonocito C, Scapaticci M, Nedovic B, Annicchiarico EB, Guarino D, Leoncini E, Boccia S, Gasbarrini A, Capoluongo E. XRCC1 Arg399Gln Gene Polymorphism and Hepatocellular Carcinoma Risk in the Italian Population. Int J Biol Markers 2017;32:190-4. [DOI: 10.5301/jbm.5000241] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 9 |
Zimmermann A. Mucinous Cystic Neoplasms (MCN) and Related Cystic Neoplasms of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2017. [DOI: 10.1007/978-3-319-26956-6_39] [Reference Citation Analysis]
|
| 10 |
Zimmermann A. Mucinous Cystic Neoplasms (MCN) and Related Cystic Neoplasms of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2016. [DOI: 10.1007/978-3-319-26587-2_39-1] [Reference Citation Analysis]
|
| 11 |
Cătană A, Pop M, Hincu BD, Pop IV, Petrişor FM, Porojan MD, Popp RA. The XRCC1 Arg194Trp polymorphism is significantly associated with lung adenocarcinoma: a case-control study in an Eastern European Caucasian group. Onco Targets Ther 2015;8:3533-8. [PMID: 26664136 DOI: 10.2147/OTT.S92361] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 12 |
Yang QI, Wei YF, Zhang Y, Huang GM. XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma susceptibility: A meta-analysis of 11 case-control studies in an Asian population. Exp Ther Med 2015;9:2406-14. [PMID: 26136996 DOI: 10.3892/etm.2015.2421] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Qin CJ, Xu KW, Chen ZH, Zhai ET, He YL, Song XM. XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis. Tumour Biol 2015;36:461-6. [PMID: 25582318 DOI: 10.1007/s13277-015-3054-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 14 |
Jiang T, Cui L, Chen L, Liu Z, Ren H. Genetic polymorphisms of XRCC1 gene and susceptibility to hepatocellular carcinoma in Chinese population. Med Oncol 2014;31:887. [PMID: 24570146 DOI: 10.1007/s12032-014-0887-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 15 |
Yi L, Xiao-Feng H, Yun-Tao L, Hao L, Ye S, Song-Tao Q. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case-control studies. PLoS One. 2013;8:e78071. [PMID: 24205095 DOI: 10.1371/journal.pone.0078071] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 16 |
Liu B, Shen T. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis. Tumor Biol 2014;35:507-12. [DOI: 10.1007/s13277-013-1071-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 17 |
Guo Q, Yang W, Zhai J, Han F, Wang C. XRCC1 codon 280 polymorphism and susceptibility to lung cancer: a meta-analysis of the literatures. Tumor Biol 2013;34:2989-94. [DOI: 10.1007/s13277-013-0863-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 18 |
Zhang Y, Wang Y, Wu J, Li LJ. XRCC1 Arg194Trp polymorphism is associated with oral cancer risk: evidence from a meta-analysis. Tumour Biol 2013;34:2321-7. [PMID: 23681796 DOI: 10.1007/s13277-013-0779-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
